Eli Health, a women's health company based in Montréal, Quebec, has raised $5 million in funding from diverse investors. The round was led by Garage Capital, Real Ventures, and Panache Ventures, with participation from Muse Capital, MEDTEQ+, Vectr Ventures, Leva Capital, TELUS Pollinator Fund for Good, RH Capital, and Cake Ventures.

Eli's mission is to improve lifelong health through continuous hormone monitoring. The company provides real-time insights from hormones in saliva, which can be tracked continuously over time, unlike traditional testing methods or send-out tests that only offer a single snapshot. With just three simple steps, Eli's at-home technology provides women with personalized hormone profiles to make informed decisions about their health.

The company is filling a data gap to transform how women manage their hormonal health in critical areas like menopause, fertility, contraception, and endocrine conditions. The support of these 10 investors will help Eli Health expand its offerings and reach more women who are looking to take control of their health and wellness. Visit us for more information about their latest funding round: https://founderlodge.com/round/Eli-Health-raises-5000000-Unknown-2023-04-06-Marina-Pavlovic-Rivas-MTE5OTU